PROMINO is a nutraceutical company specializing in the development of patented and science-based products.
PROMINO has raised $374K in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2026.
PROMINO's investors include AlphaNorth Asset Management.
PROMINO is headquartered in Burlington, Canada.
PROMINO is a nutraceutical company specializing in the development of patented and science-based products.
PROMINO is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"PROMINO — Funding & Investors." VCBacked, June 5, 2026, https://www.vcbacked.co/company/promino. Accessed November 12, 2026.
VCBacked. (2026). PROMINO — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/promino
{{cite web |title=PROMINO — Funding & Investors |url=https://www.vcbacked.co/company/promino |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at PROMINO? Request a listing update